ClinicalTrials.gg
CompletedNCT04293653(ProPEL)Updated Oct 4, 2024

Protocol for Patients Above 75 Years Undergoing Emergency Laparotomy

An interventional study of Protocol for patients above 75 undergoing emergency laparotomy or laparoscopy in Frailty, Surgery--Complications and Outcome, Fatal, sponsored by Haukeland University Hospital. Completed at 1 site in Norway. Open to participants aged 75 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-10-04.

Sponsored by Haukeland University Hospital · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
156
Allocation
Not applicable
Ages
75 Years and older
Sex
All
01

Study summary

In the ProPEL study the effect of a protocol designed for elderly patients about to undergo emergency abdominal surgery will be investigated. The protocol addresses issues of both frailty and ceiling-of -care decisions.

Read the detailed description

In the "ProPEL" study, investigators will test the effect of a care bundle designed for patients aged ≥75 years undergoing emergency laparotomy/laparoscopy. An interdisciplinary team of anesthetists, intensivists, surgeons, and geriatricians developed the care bundle, and the essential elements are frailty scoring, surveillance and optimization of patients, surgical treatment within predefined criteria, and postoperative delirium monitoring.

Preoperatively, patients with abdominal pathology requiring emergency surgery will be evaluated for frailty by the surgical team, using standardized frailty scores. Palliative care could be an alternative to surgery in very frail patients. The decision to not perform surgery is a clinical decision made with the patient and/or relatives in a shared decision-making process. Frailty scoring can assist in this procedure.

The effect of the care-bundle will be compared to a historical cohort, using 30-day mortality as the primary outcome.

02

Conditions studied

  • Frailty
  • Surgery--Complications
  • Outcome, Fatal
  • Frail Elderly Syndrome
  • Post-Op Complication
  • Gastro-Intestinal Disorder
03

In context

Frailty

1,229 studies on the registry are indexed under Frailty; 433 are open to participants now.

This study's enrollment of 156 is above the median of 80 across 704 interventional studies indexed under Frailty.

Browse Frailty studies →

Lead sponsor

Haukeland University Hospital is the lead sponsor of 283 studies on the registry; 59 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
75 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

- Patients above 75 years with clinical suspicion of abdominal condition requiring surgery

Exclusion criteria

Exclusion Criteria:

  • Former inclusion in "ProPEL"
  • Surgery for incarcerated hernia without laparotomy
  • Appendectomy without laparotomy
  • Palliative surgery for already known inoperable gastrointestinal tumor
  • Palliation without surgical treatment
  • Vascular surgery
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
156 participants (actual)

Study arms

  • Experimental
    Care bundle

    Patients above 75 years where emergency surgery is indicated, deemed fit for surgery, will be included in a perioperative care-bundle. While waiting for surgery, patients will be monitored and optimized if their condition deteriorates. Antibiotics will be administered if indicated. Surgery will be delivered within 2h to 72h, depending on the suspected abdominal pathology and the patient's clinical condition.

    Other: Protocol for patients above 75 undergoing emergency laparotomy or laparoscopy

Interventions

  • OtherProtocol for patients above 75 undergoing emergency laparotomy or laparoscopy

    See above section

06

What researchers measure

Primary outcomes

  1. Composite score of 30-day mortality and postoperative complications

    Composite score will be calculated using the Comprehensive Complication Index ranging from 0 points (uneventful postoperative recovery) to 100 points (postoperative death). One investigator will review the patient's medical record postoperatively to investigate if any medical complication has occurred. Complications are defined according to the EPCO definitions and graded according to the Clavien-Dindo classification system.

    Time frame: Up to 30 days after the performance of emergency abdominal surgery

Secondary outcomes

  1. Postoperative complications

    Number of patients having a postoperative complication as defined by the European Perioperative Clinical Outcome Definitions (EPCO) will be reported. The EPCO definitions state universal description of various common postoperative complications, like f.ex pulmonary complications, major adverse cardiac events, urinary tract infections and so on. Thus, postoperative complications are reported in a uniform way. We will grade complications according to the Clavien-Dindo classification. According to this classification postoperative complications are graded from 1 to 5, where 1 indicates least severity of complication and 5 indicating worst severity. We will report number of patients having complications from grade 2 to grade 5.

    Time frame: up to 90 days after date of emergency surgery

  2. Frequency of post-operative delirium

    Number of patients having postoperative delirium as defined by the screening tool 4 AT. On this 4-item screening tool for delirium patients are scored from 0 (minimum) up to 12 points (maximum). Screening for delirium is positive if score is 4 or above.

    Time frame: up to 30 days after emergency surgery

  3. Length of stay in hospital after EAS

    Number of days spent in hospital after EAS

    Time frame: up to 90 days after emergency surgery

  4. Patients' Level of independency as measured by the Barthel Activity of Daily Living Index before surgery and one year after surgery

    Activity of Daily Living (ADL) is measured using the Barthel ADL-index (Norwegian Version), a validated 10-item questionnaire. In this scale the patients level of functioning is described and assigned from 0 to 20 points. Zero points indicate total dependency and 20 points indicate Complete independency in Activities of Daily Living.

    Time frame: Patients will be assessed with the BArthel ADL-index when admitted to hospital and again one year after emergency abdominal surgery.

  5. Level of care at discharge from hospital and one year after EAS

    Number of patients discharged to own home after EAS. Number of patients discharged to nursing home after EAS. Number of patients living in own home or in nursing home one year after EAS.

    Time frame: 1 year after EAS.

  6. 1-year mortality

    Number of deaths within 1 year after emergency abdominal surgery (EAS)

    Time frame: From time of EAS performed and up to 1 year

  7. Days at home in first postoperative year

    Number of days living in own home first year after EAS

    Time frame: From date of discharge from hospital after EAS and up to one year postoperatively

  8. Readmissions after EAS

    Number of patients readmitted to hospital after first being discharged from hospital after EAS

    Time frame: From 8 hours after primary discharge from hospital after EAS until 30 days after primary discharge.

  9. Patient Reported Outcome Measures (PROM)one year after EAS

    Patients report on own Health performance as measured by the 36-Item Short Form Survey. In this survey patients subjective health status is described using 36 standardized questions. Patients will also be asked about their willingness to undergo same procedure again, if indicated.

    Time frame: One year after procedure performed (EAS).

  10. 5-year survival

    Number of Deaths occurring within 5 years after EAS

    Time frame: From inclusion in study and up to five years after EAS.

  11. 30-day mortality in all patients with indication to undergo surgery

    30-day mortality rate in palliative and operated patients

    Time frame: Time (days) up to 30 days after treatment decision (palliation or surgery) is made

Other outcomes

  1. 3-year survival

    Number of deaths occuring within 3 years after EAS

    Time frame: Time (days) from end of index surgery and up to 3 years after EAS.

07

Study locations

1 site
  • Haukeland University Hospital
    Bergen, 5021, Norway
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2020 to primary completion in Jun 2021, 17 months.

Of 477 non-industry interventional studies with no phase under Frailty, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 40. This study's 17 months is below that.

Counting every sponsor, half of 484 studies reached it within 21 months; a quarter within 9 and three quarters within 39.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 2, 2020
First posted
Mar 3, 2020
StartActual
Jan 21, 2020
Primary completionActual
Jun 30, 2021
CompletionActual
Oct 2, 2024
Last update
Oct 4, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 4, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04293653
Responsible party
Sponsor
First posted
Mar 3, 2020
Start date
Jan 21, 2020
Primary completion
Jun 30, 2021
Completion
Oct 2, 2024
Last update
Oct 4, 2024

Study contacts

Ib Jammer, MD, PhD
principal investigator

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion